These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17982963)

  • 1. Type 2 diabetes and impaired glucose tolerance among cardiac patients.
    Enquobahrie DA; Dolidze N; Chapidze G; Vadachkoria S; Soh J; Fitzpatrick A; Williams MA
    Acta Cardiol; 2007 Oct; 62(5):439-44. PubMed ID: 17982963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program.
    Rodriguez BL; Curb JD; Burchfiel CM; Huang B; Sharp DS; Lu GY; Fujimoto W; Yano K
    Diabetes Care; 1996 Jun; 19(6):587-90. PubMed ID: 8725856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T; Moilanen L; Jokelainen J; Korpi-Hyövälti E; Vanhala M; Saltevo J; Niskanen L; Peltonen M; Oksa H; Cederberg H; Tuomilehto J; Uusitupa M; Keinänen-Kiukaanniemi S
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical implications of impaired glucose tolerance.
    Alberti KG
    Diabet Med; 1996 Nov; 13(11):927-37. PubMed ID: 8946150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between egg consumption and cardiovascular disease events, diabetes and all-cause mortality.
    Guo J; Hobbs DA; Cockcroft JR; Elwood PC; Pickering JE; Lovegrove JA; Givens DI
    Eur J Nutr; 2018 Dec; 57(8):2943-2952. PubMed ID: 29098427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral glucose tolerance testing as a complement to fasting plasma glucose in screening for type 2 diabetes: population-based cross-sectional analyses of 146 000 health examinations in Västerbotten, Sweden.
    Rosén A; Otten J; Stomby A; Vallin S; Wennberg P; Brunström M
    BMJ Open; 2022 Jun; 12(6):e062172. PubMed ID: 35676014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Cheng KK; Yue XJ; Lin JM; Zhang WS; Thomas GN
    Metabolism; 2010 Mar; 59(3):367-72. PubMed ID: 19828159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose.
    Li CH; Wu JS; Yang YC; Shih CC; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E658-62. PubMed ID: 22337914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary and perspectives on impaired glucose tolerance.
    Genuth S
    Diabet Med; 1996; 13(3 Suppl 2):S29-31. PubMed ID: 8689860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study.
    Boas Soja AM; Zwisler AD; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):784-90. PubMed ID: 17001219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
    Sanusi H
    Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.